Vera Therapeutics VERA Return on invested capital

Return on invested capital at other companies

Vertex PharmaceuticalsVRTX

28.4%+1.4pp

Travere Therapeutics, Inc.TVTX

-118%-48.4pp

Aurinia PharmaceuticalsAUPH

33.7%+20.8pp

Climb Bio, Inc.CLYM

-39.4%-15.9pp

Jade BiosciencesJBIO

-104%+2,762pp

Viridian Therapeutics, Inc.VRDN

-78.5%-6.2pp

FAQ

What is Vera Therapeutics's return on invested capital?

Vera Therapeutics (VERA) reported return on invested capital of -77.1% in Q1 2026.

How has Vera Therapeutics's return on invested capital changed year-over-year?

Vera Therapeutics's return on invested capital decreased by 73.9% year-over-year, from -44.3% to -77.1%.

What is the long-term trend for Vera Therapeutics's return on invested capital?

Over 3 years (2022 to 2025), Vera Therapeutics's return on invested capital has grown at a -35.3% compound annual growth rate (CAGR), from -269.4% to -72.8%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.